Skip to main content
Premium Trial:

Request an Annual Quote

GNF Renews License to Ingenuity's Pathways Analysis Software

NEW YORK (GenomeWeb News) - Ingenuity Systems today said that the Genomics Institute of the Novartis Research Foundation has renewed and expanded a licensing agreement for its pathway analysis software.
 
The licensing deal grants GNF continued use of Ingenuity's Pathway Analysis software for the institute's research in RNA profiling, Ingenuity said. GNF originally licensed the software in 2003.
 
IPA is designed for pathway modeling and analysis in biomarker, toxicology, and pharmacogenomics research.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.